Juan Pinelli
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research
Papers in
- Surgery 3
- Bladder and Urothelial Cancer Treatments 3
- Urinary and Genital Oncology Studies 3
-
- Metabolism, Diabetes, and Cancer 1
- Wnt/β-catenin signaling in development and cancer 1
- Co-authors
- Elaina M. Gartner (2 shared papers)Bradley A. McGregor (3 shared papers)Daniel P. Petrylak (3 shared papers)Peter H. O’Donnell (3 shared papers)Jonathan E. Rosenberg (3 shared papers)Amal Melhem‐Bertrandt (2 shared papers)Noah M. Hahn (2 shared papers)Elisabeth I. Heath (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Blood (3 papers)Bone Marrow Transplantation (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Juan Pinelli
7 papers receiving 651 citations
Juan Pinelli's Hit Papers
Peers
Comparison fields: 5 of 53
- Oncology 331
- Dermatology 80
- Pathology and Forensic Medicine 161
- Surgery 322
- Immunology 76
Countries citing papers authored by Juan Pinelli
This map shows the geographic impact of Juan Pinelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Pinelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Pinelli more than expected).
Fields of papers citing papers by Juan Pinelli
This network shows the impact of papers produced by Juan Pinelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Pinelli. The network helps show where Juan Pinelli may publish in the future.
Co-authors
The 25 scholars most cited alongside Juan Pinelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy Hit paper breakdown → | 2019 | 435 |
| 2 | 2017 | 161 | |
| 3 | 2019 | 37 | |
| 4 | 2016 | 13 | |
| 5 | 2016 | 5 | |
| 6 | 2019 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2024 | 0 |
About Juan Pinelli
Juan Pinelli is a scholar working on Surgery, Molecular Biology, Pathology and Forensic Medicine, Dermatology and Oncology, having authored 8 papers that have together received 655 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (3 papers), Urinary and Genital Oncology Studies (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Cutaneous lymphoproliferative disorders research (2 papers), Diabetes Management and Research (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Wnt/β-catenin signaling in development and cancer (1 paper). The work is most often cited by research in Oncology (331 citations), Dermatology (80 citations), Pathology and Forensic Medicine (161 citations), Surgery (322 citations) and Immunology (76 citations). Juan Pinelli has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Elaina M. Gartner, Bradley A. McGregor, Daniel P. Petrylak, Peter H. O’Donnell, Jonathan E. Rosenberg, Amal Melhem‐Bertrandt, Noah M. Hahn, Elisabeth I. Heath, Arjun Vasant Balar and Evan Y. Yu. Their work appears in journals such as Journal of Clinical Oncology, Blood, Bone Marrow Transplantation and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.